Cardiomyocytes Derived from Human ^{Cardiopoietic}Amniotic Fluids

Area of Science:

• Stem cell biology
• Cardiovascular research
• Regenerative medicine

Background:

• Human amniotic fluid (hAF) cells possess multipotent stem cell characteristics.
• While hAF cells can differentiate into various cell types, terminal differentiation into cardiomyocytes (CMs) has not been achieved.
• Identifying specific hAF cell populations for cardiac differentiation is crucial.

Purpose of the Study:

• To promote and characterize cardiac differentiation in hAF cells.
• To investigate the potential of a specific hAF cell subset for cardiomyocyte development.

Main Methods:

• hAF cells were cultured and exposed to cardiac differentiation-inducing factors for 15 days.
• Flow cytometry and immunofluorescence were used to identify multipotency markers (SSEA4, OCT4, CD90) and cardiac-specific markers.
• Functional assays assessed calcium handling and response to adrenergic stimulation.

Main Results:

• A subset of hAF cells, termed Cardiopoietic AF cells, expressing SSEA4, OCT4, and CD90, responded to differentiation.
• Differentiated cells showed increased expression of cardiac transcription factors (Nkx2.5, GATA4), sarcomeric proteins (cTnT, α-MHC), Connexin43, and atrial/ventricular markers.
• Cardiopoietic AF-derived cells exhibited cardiac-specific calcium handling (CACNA1C, SERCA2a) and responded to pharmacological stimulation, with some showing spontaneous beating.

Conclusions:

• Cardiopoietic AF cells can differentiate into cardiomyocyte-like cells.
• These cells possess molecular, structural, and functional properties characteristic of cardiomyocytes.
• This study demonstrates a novel pathway for generating CM-like cells from hAF for potential therapeutic applications.